Episurf Medical AB (publ) (FRA:16E)

Episurf Medical AB Statistics

Total Valuation

FRA:16E has a market cap or net worth of EUR 5.42 million. The enterprise value is 5.22 million.

Market Cap	5.42M
Enterprise Value	5.22M

Important Dates

The last earnings date was Friday, February 6, 2026.

Earnings Date	Feb 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	1.66B
Shares Outstanding	n/a
Shares Change (YoY)	+99.37%
Shares Change (QoQ)	+57.02%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.38B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.91
PB Ratio	1.24
P/TBV Ratio	1.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.97
EV / Sales	2.76
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.10.

Current Ratio	1.70
Quick Ratio	1.21
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-96.33

Financial Efficiency

Return on equity (ROE) is -88.65% and return on invested capital (ROIC) is -52.17%.

Return on Equity (ROE)	-88.65%
Return on Assets (ROA)	-45.84%
Return on Invested Capital (ROIC)	-52.17%
Return on Capital Employed (ROCE)	-117.00%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	103,697
Profits Per Employee	-298,769
Employee Count	18
Asset Turnover	0.26
Inventory Turnover	3.26

Taxes

In the past 12 months, FRA:16E has paid 27,721 in taxes.

Income Tax	27,721
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.33% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-99.33%
50-Day Moving Average	0.00
200-Day Moving Average	0.00
Relative Strength Index (RSI)	48.14
Average Volume (20 Days)	434

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:16E had revenue of EUR 1.87 million and -5.38 million in losses. Loss per share was -0.01.

Revenue	1.87M
Gross Profit	933,269
Operating Income	-5.34M
Pretax Income	-5.35M
Net Income	-5.38M
EBITDA	-4.82M
EBIT	-5.34M
Loss Per Share	-0.01

Balance Sheet

The company has 656,060 in cash and 452,774 in debt, with a net cash position of 203,286.

Cash & Cash Equivalents	656,060
Total Debt	452,774
Net Cash	203,286
Net Cash Per Share	n/a
Equity (Book Value)	4.39M
Book Value Per Share	0.00
Working Capital	674,541

Cash Flow

Operating Cash Flow	-5.11M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 50.00%, with operating and profit margins of -286.14% and -288.12%.

Gross Margin	50.00%
Operating Margin	-286.14%
Pretax Margin	-286.63%
Profit Margin	-288.12%
EBITDA Margin	-258.42%
EBIT Margin	-286.14%
FCF Margin	n/a

Dividends & Yields

FRA:16E does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-99.37%
Shareholder Yield	-99.37%
Earnings Yield	-99.14%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:16E has an Altman Z-Score of -18.72 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-18.72
Piotroski F-Score	3